At the same time, this study found that ZCCHC17 is involved in immune-related pathways in HCC patients and is also related to multiple immunotherapy-related targets (immune checkpoint genes, TMB, MSI). The gene discussed is ZCCHC17; the disease is hepatocellular carcinoma.